genes (GRIN2B, GRIK3, GRIA
1, GRIN
1). Three SNPs were associated with type 2 diabetes: rs7301328 in GRIN2
Ivanov, A.M.,
Gil'manov, A.Z.,
Malyutina, N.N.,
Khovaeva, Y.B.,
Nenasheva, O.Y.,
El'kin, G.I.,
Sosnin, D.Y. (2020) in blood serum for the remaining 4 SNP in folate cycle
genes (р> 0.
1). Examined SNP in MTHFR and MTR
genesFACHAL, L.,
KAR, S.,
TYRER, J.P.,
GHOUSSAINI, M.,
HARRINGTON, P.A.,
HEALEY, C.S.,
MAYES, R.,
SHAH, M.,
PHAROAH, P.D.P.,
EASTON, D.F.,
DUNNING, A.M.,
ASCHARD, H.,
JIANG, X.,
TAMIMI, R.M.,
KHUSNUTDINOVA, E.,
BIAŁKOWSKA, K.,
и др. соавторы (2020) significantly over-represented in active
gene regulatory regions and transcription factor binding sites. We
Erdman, V.V.,
Nasibullin, T.R.,
Tuktarova, I.A.,
Timasheva, Y.R.,
Danilko, K.V.,
Viktorova, T.V.,
Mustafina, O.E. (2020) the polymorphic markers in the
genes of the antioxidant defense enzymes—SOD
1 (rs2070424), SOD2 (rs4880), and SOD3
KLIMENTOVA, E.A.,
GILYAZOVA, I.R.,
BERMISHEVA, M.A.,
BLINNIKOVA, A. M.,
SAFIULLIN, R.I.,
IZMAILOV, A.A.,
YANG, B.,
PAVLOV ., V.N,
KHUSNUTDINOVA, E.K. (2020) are accompanied by inactivation of the von Hippel–Lindau
gene (VHL). It is known that VHL is a target for several
DAVYDOVA, Y.,
KAZANTSEVA, A.,
ENIKEEVA, R.,
MUSTAFIN, R.,
MALYKH, S.,
LOBASKOVA, M.,
VALINUROV, R.,
AKHMEROVA, I.,
KHUSNUTDINOVA, E. (2020) hereditary, but specific
gene-environmental (G ×E) mechanisms mediating the genetic risk for aggres- sion
KURKINA, M.V.,
MIHAYLOVA, S.V.,
BAIDAKOVA, G.V.,
SAIFULLINA, E.V.,
KOROSTELEV, S.A.,
PYANKOV, D.V.,
KANIVETS, I.V.,
YUNIN, M.A.,
PECHATNIKOVA, N.L.,
ZAKHAROVA, E.YU (2020) detected in two patients.
Genes located in the area of imbalance were KLF
1, DNASE2, and GCDH. Patients